Non‐alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor

Koji Sawada, Hidemi Hayashi, Shunsuke Nakajima, +3

Journal of Gastroenterology and Hepatology

Daikenchuto (TU‐100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K

Takumu Hasebe, Nobuhiro Ueno, Mark W. Musch, +10

Pharmacology Research & Perspectives

Butyrate and bioactive proteolytic form of Wnt-5a regulate colonic epithelial proliferation and spatial development

Kazuhiko Uchiyama, Toshio Sakiyama, Takumu Hasebe, +11

Scientific Reports

Augmented hepatic <scp>T</scp>oll‐like receptors by fatty acids trigger the pro‐inflammatory state of non‐alcoholic fatty liver disease in mice

Koji Sawada, Takaaki Ohtake, Takumu Hasebe, +7

Hepatology Research

Successful Treatment of Nivolumab-related Cholangitis with Prednisolone: A Case Report and Review of the Literature

Koji Sawada, Tatsuya Shonaka, Yuji Nishikawa, +8

Internal Medicine

Successful TreatmentImmunologyGastroenterologyPathologySurgery +16

TU-100 (Daikenchuto) and Ginger Ameliorate Anti-CD3 Antibody Induced T Cell-Mediated Murine Enteritis: Microbe-Independent Effects Involving Akt and NF-κB Suppression

Nobuhiro Ueno, Takumu Hasebe, Atsushi Kaneko, +9

PLoS ONE

Microbial PathogensJapanese PepperAnti-cd3 Antibody ActivationImmunologyImmune Regulation +20

Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model

Takumu Hasebe, Hiroki Tanaka, Koji Sawada, +4

Journal of Gastroenterology

Polymorphism of receptor‐type tyrosine‐protein phosphatase delta gene in the development of non‐alcoholic fatty liver disease

Shunsuke Nakajima, Hiroki Tanaka, Koji Sawada, +6

Journal of Gastroenterology and Hepatology

Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: A novel therapy exploiting tumor‐platelet interactions

Hiroki Tanaka, Kie Horioka, Takumu Hasebe, +9

International Journal of Cancer

PathologyAbundant SorafenibPharmacotherapyAutologous PlateletsTumor Biology +15

Skeletal muscle mass is associated with toxicity, treatment tolerability, and additional or subsequent therapies in patients with hepatocellular carcinoma receiving sorafenib treatment

Koji Sawada, Yoshinori Saitho, Hidemi Hayashi, +5

JGH Open